Melbourne's Peter MacCallum Cancer Centre to be home of 'the next great wave in treatment'

25 March 2019 - A new form of cancer treatment that uses cell therapy to attack the disease will become ...

Read more →

Prescription drug prices are out of control

17 March 2019 - In an all-too-rare example of political consensus, congressional law makers on both sides of the aisle ...

Read more →

What 1 April 2019 private health insurance changes mean for you

17 March 2019 - When the calendar flips to April 1 this year, many private health insurance customers will need ...

Read more →

Toward a strategy to involve patients in health technology assessment in Spain

14 March 2019 - The aim of this study was to develop a feasible and effective strategy to involve patients in ...

Read more →

On the use of list prices in drug pricing research

14 March 2019 - In the limitations section of this article, we discussed in detail that list prices do not capture ...

Read more →

'Have you got insurance?': the US style question finding its way to Australian hospitals

16 March 2019 - “Have you got insurance?” It is the first question faced by any patient walking into a ...

Read more →

Statement from FDA Commissioner and Director of the Center for Devices and Radiological Health on efforts to evaluate materials in medical devices to address potential safety questions

15 March 2019 - We’re in an unprecedented era of innovation in medical devices with advances in materials science that ...

Read more →

Women with advanced breast cancer ask the PM to intervene

15 March 2019 - On Wednesday 13 March, ten women with advanced breast cancer presented to the Health Select Committee to ...

Read more →

Obama 'missed opportunity' to address drug costs in Obamacare

15 March 2019 - Democratic presidential candidate Sen. Amy Klobuchar said not doing more to address prescription drug prices in ...

Read more →

European Commission approves Roche’s MabThera (rituximab) for a rare auto-immune disease

15 March 2019 - MabThera is now approved in Europe to treat four auto-immune diseases. ...

Read more →

Institute for Clinical and Economic Review publishes revised protocol for assessing unsupported price increases for prescription drugs

15 March 2019 - Through April 19, ICER is accepting public input on which additional price increases should be included ...

Read more →

Spectrum Pharmaceuticals provides BLA filing update for Rolontis (eflapegrastim)

15 March 2019 - Spectrum Pharmaceuticals announced today that due to the U.S. FDA's request for additional manufacturing-related information for ...

Read more →

PBAC Public Summary Documents - November 2018 meeting (rejections and deferrals)

15 March 2019 - The Public Summary Documents (first time rejections and deferrals) from the November 2018 PBAC meeting are now ...

Read more →

Health Canada begins release of clinical data on drugs and devices

14 March 2019 - Health Canada launched two public databases on Wednesday as the first step in making clinical information ...

Read more →

Eton Pharmaceuticals submits new drug application for DS-200

14 March 2019 - FDA previously granted DS-200 fast track designation. ...

Read more →

Karyopharm announces FDA extension of review period for selinexor new drug application

14 March 2019 - PDUFA action date extended by three months to July 6, 2019. ...

Read more →